MoneyWorks4Me

The sales figure stood at Rs. 1674.08 millions for the March 2025 quarter. The mentioned figure indicates a growth of about 41.83% as compared to Rs. 1180.33 millions during the year-ago period.A comparatively good net profit growth of 39.68% to Rs. 70.72 millions was reported for the quarter ended March 2025 compared to Rs. 50.63 millions of previous same quarter.The company reported a good operating profit of 174.39 millions compared to 111.67 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1674.08 1180.33 41.83 4562.68 3490.72 30.71 4562.68 3490.72 30.71
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 174.39 111.67 56.17 550.97 388.98 41.64 550.97 388.98 41.64
Interest 81.47 43.72 86.34 223.77 136.50 63.93 223.77 136.50 63.93
PBDT 92.92 67.95 36.75 327.20 252.48 29.59 327.20 252.48 29.59
Depreciation 12.50 9.56 30.75 44.49 37.96 17.20 44.49 37.96 17.20
PBT 80.42 58.39 37.73 282.71 214.52 31.79 282.71 214.52 31.79
TAX 9.70 7.76 25.00 74.63 58.28 28.05 74.63 58.28 28.05
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 70.72 50.63 39.68 208.08 156.24 33.18 208.08 156.24 33.18
Equity 47.22 46.99 0.49 47.22 46.99 0.49 47.22 46.99 0.49
PBIDTM(%) 10.42 9.46 10.11 12.08 11.14 8.37 12.08 11.14 8.37
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..